Novavax

News

Novavax critic Shah Capital ends its activism campaign

Shah Capital has ended attempts to exert influence over vaccine firm Novavax, bringing more than years of pressure on management to an end.

News

Activist investor renews its criticism of Novavax

Shah Capital has fired another broadside at vaccine firm Novavax, accusing its board and management of a "destruction in shareholder value."

News

Novavax CEO John Jacobs and Sah Capital's founder Himanshu Shah

Investor seeks sale of Novavax after poor COVID jab sales

Investor Shah Capital has called on Novavax's board to put the company up for sale, citing a "litany of missteps" at the vaccine developer.

News

FDA finally okays Novavax's COVID-19 jab, with restrictions

The FDA has granted full approval to Novavax's COVID-19 vaccine after a delay, but has limited its use.

News

Medical gloved hands fill a vaccine into a syringe

Does the Novavax delay augur a COVID vaccine policy change?

Statements from HHS suggest new hurdles could be coming for seasonal COVID formulations, though the picture is still unclear.

News

COVID-19 vaccinations now ‘alarmingly low’ in Europe

COVID-19 vaccination rates have fallen precipitously in Europe and should be ramped up this autumn so they are at least in line with influenza vaccine uptake.

Novavax critic Shah Capital ends its activism campaign

Activist investor renews its criticism of Novavax

Investor seeks sale of Novavax after poor COVID jab sales

FDA finally okays Novavax's COVID-19 jab, with restrictions

Does the Novavax delay augur a COVID vaccine policy change?

COVID-19 vaccinations now ‘alarmingly low’ in Europe

Flagship joins three biotechs together to form Etcelera

Discover a new era of healthcare panel engagement: Grounded ...

Novavax

Editor's Picks